Skip to content

H.R. 1117 · 118th Congress (2023–2025)

Advancing Safe Medications for Moms and Babies Act of 2023

This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research.

For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research.

The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance of including pregnant and lactating women in clinical research.

The National Institutes of Health must also prioritize certain research projects on new and existing medications for pregnant and lactating women based on need, feasibility, and the potential impact of the research.

Show official title

To implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 1117’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Kathy Castor (D-FL-14)
Cosponsors
30 cosponsors

2 original · 28 later

2 R · 28 D

  1. Rep. Brian K. Fitzpatrick (R-PA-1)· Original · Feb 21, 2023
  2. Rep. Lauren Underwood (D-IL-14)· Original · Feb 21, 2023
  3. Rep. Suzan K. DelBene (D-WA-1)· Later · Mar 9, 2023
  4. Rep. Ann M. Kuster (D-NH-2)· Later · Mar 9, 2023
  5. Rep. Joseph D. Morelle (D-NY-25)· Later · Mar 9, 2023
  6. Rep. Wiley Nickel (D-NC-13)· Later · Mar 9, 2023
  7. Rep. Chris Pappas (D-NH-1)· Later · Mar 9, 2023
  8. Rep. Rashida Tlaib (D-MI-12)· Later · Mar 9, 2023
  9. Rep. Susan Wild (D-PA-7)· Later · Mar 9, 2023
  10. Rep. Lisa Blunt Rochester (D-DE)· Later · Apr 6, 2023
  11. Rep. Sean Casten (D-IL-6)· Later · Apr 6, 2023
  12. Rep. Sharice Davids (D-KS-3)· Later · Apr 6, 2023
  13. Rep. Robert Menendez (D-NJ-8)· Later · Apr 13, 2023
  14. Rep. Yadira Caraveo (D-CO-8)· Later · May 15, 2023
  15. Rep. Josh Gottheimer (D-NJ-5)· Later · May 15, 2023
  16. Rep. Mary Sattler Peltola (D-AK)· Later · May 15, 2023
  17. Rep. Robin L. Kelly (D-IL-2)· Later · May 31, 2023
  18. Rep. Stephen F. Lynch (D-MA-8)· Later · Jul 6, 2023
  19. Rep. Daniel S. Goldman (D-NY-10)· Later · Aug 29, 2023
  20. Rep. Mark Pocan (D-WI-2)· Later · Aug 29, 2023
  21. Rep. Colin Z. Allred (D-TX-32)· Later · Sep 20, 2023
  22. Rep. Kathy E. Manning (D-NC-6)· Later · Sep 20, 2023
  23. Rep. Jerrold Nadler (D-NY-12)· Later · Sep 20, 2023
  24. Rep. Chellie Pingree (D-ME-1)· Later · Sep 20, 2023
  25. Rep. Terri A. Sewell (D-AL-7)· Later · Oct 24, 2023
  26. Rep. Angie Craig (D-MN-2)· Later · Nov 28, 2023
  27. Rep. Scott H. Peters (D-CA-50)· Later · Nov 28, 2023
  28. Rep. Lois Frankel (D-FL-22)· Later · Jan 10, 2024
  29. Rep. Alma S. Adams (D-NC-12)· Later · Feb 28, 2024
  30. Rep. Don Bacon (R-NE-2)· Later · Apr 10, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Feb 21, 2023 – Mar 3, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Feb 21, 2023
  2. HouseHealthReferred Mar 3, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Advancing Safe Medications for Moms and Babies Act of 2023

    Display title, Short title · Introduced in House

  2. To implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research, and for other purposes.

    Official title · Introduced in House